Australian Genome Research Facility – 2000

cancer-researcher-kitty-pipetting2000 – $1.3 million research grant
Research Institution: Australian Genome Research Facility – Microarray Consortium Melbourne, Victoria & Brisbane, Queensland
Director of Research: President Erik Thompson, Vice President Ian Dawes
Feature Outcome: This grant was used toward a vast array of outcomes including the staging of the 3rd Australian Microarray conference.

Further Details/ Outcomes:

  • Staging of the 3rd Australian Microarray conference, with nine international speakers and 125 registrants. The meeting was highly successful both scientifically and economically.
  • Successful utilisation of the Compugen gene array oligonucleotides. The Consortium is now a leading supplier of microarray chips to Australian universities and research institutes.
  • Planning of the Incorporation of the ACRF Microarray Consortium: AMATA
  • Organisation of the ormicroarray bioinformatics workshop by Dr Mark Waltham at St. Vincent’s Hospital. The workshop attracted participants from nearly every consortium node.
  • The Garvan Institute in Sydney was formally admitted as a new Node to the ACRF Microarray Consortium to ensure representation of the Affymetrix platform.
  • Initiation of discussion with Millenium Sciences for a National Affymetrix Chip deal again using the national buying power to reduce costs. The Adelaide Microarray Facility produced 200 Human 8K cDNA arrays, 370 Human 19K Oligonucleotide arrays and 120 Mouse 22K Oligonucleotide arrays.
  • The IMB node relocated to the new Queensland Bioscience Precinct and the microarray facility was closed for seven months. Despite this, they managed to print 1000 mouse Compugen oligo arrays in 2003 that were used by groups in QLD, VIC, SA and WA.
  • The AGRF node produced 298 Human 8k slides & 55 Human 19k slides.
  • The UNSW node produced 190 Human 6K cDNA arrays, 750 Human 19K oligonucleotide arrays, 470 Mouse 22K oligonucleotide arrays and 235 Rat 10K oligonucleotide arrays.
  • The WA node known as the Lottery west State Microarray Facility (LSMAF) took possession of a piezoelectric microspotting device, and emphasis was placed on the manufacture of target and custom arrays for the WA research community, and the provision of hardware for Affymetrix technology.
  • The PMCI Node produced 1725 human 10.5K, 375 Mouse 15K, 75 Wallaby 10K, 150 human 19K slides.
  • Dr Andrew Holloway, head of the PeterMac Microarray Facility, announced that microarray technology developed in his facility allowed a more precise diagnosis of cancer, and the ability to monitor the efficacy of treatment.